• Wiley Online Library will be disrupted on 26 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Original Article

You have full text access to this OnlineOpen article

A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia

  1. Masahiko Sato*,
  2. Jianliang Lu,
  3. Stephen Iturria,
  4. Keith R Stayrook,
  5. Lorri L Burris,
  6. Qing Qiang Zeng,
  7. Allen Schmidt,
  8. Robert J Barr,
  9. Chahrzad Montrose-Rafizadeh,
  10. Henry U Bryant,
  11. Yanfei L Ma

Article first published online: 14 JAN 2010

DOI: 10.1002/jbmr.15

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 25, Issue 6, pages 1326–1336, June 2010

Additional Information

How to Cite

Sato, M., Lu, J., Iturria, S., Stayrook, K. R., Burris, L. L., Zeng, Q. Q., Schmidt, A., Barr, R. J., Montrose-Rafizadeh, C., Bryant, H. U. and Ma, Y. L. (2010), A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia. J Bone Miner Res, 25: 1326–1336. doi: 10.1002/jbmr.15

Author Information

  1. Lilly Research Laboratories, Indianapolis, IN, USA

*MC7R2, Lilly Research Laboratories, Indianapolis, IN 46285, USA.

Publication History

  1. Issue published online: 27 MAY 2010
  2. Article first published online: 14 JAN 2010
  3. Accepted manuscript online: 14 JAN 2010 12:00AM EST
  4. Manuscript Accepted: 29 DEC 2009
  5. Manuscript Revised: 14 NOV 2009
  6. Manuscript Received: 2 MAY 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (271K)

References

  • 1
    Siris ES, Selby PL, Saag KG, Borgstrom F, Herings RM, Silverman SL. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. American Journal of Medicine. 2009; 122 (Suppl-13).
  • 2
    Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. New England Journal of Medicine. 2007; 357: 905–916.
  • 3
    Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis [see comment]. New England Journal of Medicine. 2001; 344: 1434–1441.
  • 4
    Seeman E, Compston J, Adachi J, et al. Non-compliance: the achilles heel of anti-fracture efficacy. Osteoporosis International. 2007; 18: 711–719.
  • 5
    Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin d and dose dependency a meta-analysis of randomized controlled trials. Archives of Internal Medicine. 2009; 169: 551–561.
  • 6
    Orimo H, Shiraki M, Hayashi Y, et al. Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcified Tissue International. 1994; 54: 370–376.
  • 7
    Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. New England Journal of Medicine. 1992; 327: 1637–1642.
  • 8
    DeLuca HF. Overview of general physiologic features and functions of vitamin D. American Journal of Clinical Nutrition. 2004; 80 (Suppl-96S).
  • 9
    Chen JT, Shiraki M, Hasumi K, et al. 1-α-Hydroxyvitamin D3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women. Bone. 1997; 20: 557–562.
  • 10
    Matsumoto T, Miki T, Hagino H, et al. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial. Journal of Clinical Endocrinology & Metabolism. 2005; 90: 5031–5036.
  • 11
    Bouillon R, Van CS, Carmeliet G. Intestinal calcium absorption: Molecular vitamin D–mediated mechanisms. Journal of Cellular Biochemistry. 2003; 88: 332–339.
    Direct Link:
  • 12
    Bouillon R, Verlinden L, Eelen G, De CP, Vandewalle M, Mathieu C, Verstuyf A. Mechanisms for the selective action of Vitamin D analogues. Journal of Steroid Biochemistry & Molecular Biology. 2005; 97: 21–30.
  • 13
    Bikle D. Nonclassic actions of vitamin D. Journal of Clinical Endocrinology & Metabolism. 2009; 94: 26–34.
  • 14
    Erben Reinhold G, Scutt Andrew M, Miao D, Kollenkirchen U, Haberey M. Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow. Endocrinology. 1997; 138: 4629–4635.
  • 15
    Erben Reinhold G, Bromm S, Stangassinger M. Therapeutic efficacy of 1α,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1α,25-dihydroxyvitamin D3 on bone. Endocrinology. 1998; 139: 4319–4328.
  • 16
    Shiraishi A, Takeda S, Masaki T, et al. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. Journal of Bone & Mineral Research. 2000; 15: 770–779.
    Direct Link:
  • 17
    Uchiyama Y, Higuchi Y, Takeda S, et al. ED-71, a vitamin D analogue, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone. 2002; 30: 582–588.
  • 18
    Khanal RC, Nemere I. Regulation of intestinal calcium transport. Annual Review of Nutrition. 2008; 28: 179–196.
  • 19
    Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D–mediated human antimicrobial response. Science. 2006; 311: 1770–1773.
  • 20
    Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006; 124: 823–835.
  • 21
    Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Progress in Biophysics & Molecular Biology. 2006; 92: 60–64.
  • 22
    Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmunity Reviews. 2006; 5: 114–117.
  • 23
    Holick MF. Vitamin D: its role in cancer prevention and treatment. Progress in Biophysics & Molecular Biology. 2006; 92: 49–59.
  • 24
    Spina CS, Ton L, Yao M, et al. Selective vitamin D receptor modulators and their effects on colorectal tumor growth. Journal of Steroid Biochemistry & Molecular Biology. 2007; 103: 757–762.
  • 25
    Bischoff-Ferrari HA, Orav EJ, wson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Archives of Internal Medicine. 2006; 166: 424–430.
  • 26
    Ma Y, Khalifa B, Yee YK, et al. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. Journal of Clinical Investigation. 2006; 116: 892–904.
  • 27
    Dixon KM, Mason RS. Vitamin D. International Journal of Biochemistry & Cell Biology. 2009; 41: 982–985.
  • 28
    Sato M, Zeng GQ, Turner CH. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats. Endocrinology. 10/1997; 138: 4330–4337.
  • 29
    Burtis CA, Ashwood ER. Tietz Fundamentals of Clinical Chemistry. 5th Edition. In: SolbergHE, ed. Establishment and Use of Reference Values. International Federation of Clinical Chemistry, 2001: pp. 251–261.
  • 30
    FDA, Food and Drug Administration 2004 Draft Guidance for Industry on the Preclinical and Clinical Evaluation of Agents used in the Prevention or Treatment of Postmenopausal Osteoporosis: Request for Comments., 69 ed., pp. 6673–6675.
  • 31
    European Medicines Agency 2005 Guideline on the Evaluation of New Medicinal Products in the Treatment of Osteoporosis.
  • 32
    Tsurukami H, Nakamura T, Suzuki K, Sato K, Higuchi Y, Nishii Y. A novel synthetic vitamin D analogue, 2β-(3-hydroxypropoxy)1α,25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats. Calcified Tissue International. 1994; 54: 142–149.
  • 33
    Onyia JE, Helvering LM, Gelbert L, et al. Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray. Journal of Cellular Biochemistry. 2005; 95: 403–418.
    Direct Link:
View Full Article (HTML) Get PDF (271K)